| Line Item | 2025-10-31 | Y/Y |
|---|---|---|
| Revenue | $34.30B | +13.8% |
| R&D Expense | $2.52B | +12.1% |
| SG&A Expense | $5.70B | +17.1% |
| Operating Income | -$437.0M | -120.0% |
| Interest Expense | $1.10B | +41.3% |
| Pre-tax Income | -$285.0M | -109.7% |
| Income Tax | -$342.0M | -191.4% |
| Net Income | $57.0M | -97.8% |
| EPS (Basic) | -$0.04 |
| Line Item | 2025-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.77B | -61.1% |
| Accounts Receivable | $5.29B | +49.0% |
| Inventory | $6.35B | -18.7% |
| Current Assets | $24.99B | -25.3% |
| Total Assets | $75.91B | +6.5% |
| Current Liabilities | $24.64B | -5.1% |
| Long-term Debt | $21.75B | +23.1% |
| Line Item | 2025-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.92B | -32.8% |
| Investing Cash Flow | -$13.19B | — |
| Financing Cash Flow | $1.05B | -83.4% |
| -102.1% |
| EPS (Diluted) | -$0.04 | -102.1% |
| Stockholders' Equity |
| $24.69B |
| -0.5% |